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Abstract: The effect of ketamine, a drug commonly used as an anesthetic, on monoaminergic neurotransmitters and GABA in
neurocytes from fetal rats has not yet been elucidated. We thus decided to investigate these effects by first evaluating ketamine levels
in the cerebrospinal fluid by high-performance liquid chromatography. We thus determined the concentrations of GABA, DA, NE,
5-HT, and 5-HIAA following the addition of four different concentrations of ketamine at day 7 of nerve cell culture. GABA, 5-HT, and
5-HIAA levels were increased after an initial decrease: they showed the lowest levels at 10–15 min and the highest peaks at 45–90 min,
followed by a declining trend. On the other hand, the trends of DA and NE levels were opposite. These changes in neurotransmitter
levels showed a significant impact on monoamine neurotransmitters and GABA, consistent with the clinical changes in anesthetized
rats. The role of ketamine in anesthesia may be explained by the changing levels of these indicators. Ketamine may be involved in the
inhibition of the production and storage of excitatory neurotransmitters and the promotion of the generation and storage of inhibitory
neurotransmitters, exerting its anesthetic action by reducing messenger molecules and related enzyme activity.
Key words: Ketamine, neurocytes, rat, monoamine neurotransmitters, GABA

1. Introduction
Ketamine can selectively inhibit specific parts of the
central nervous system, especially at the level of the
communication channel and the thalamocortical
network of the brain. Ketamine is characterized by its
peculiar ability to separate pain and consciousness, called
“separation anesthesia” (1).
Classical ion receptor channels are mainly
activated by norepinephrine (NE), dopamine (DA),
5-hydroxytryptamine (5-HT), 5-hydroxyindoleacetic
acid (5-HIAA), and γ-aminobutyric acid (GABA). These
neurotransmitters not only regulate neuronal excitability
but also have a strong impact on the development of
the brain. For example, DA is retained in vesicles at the
nerve endings. When a nerve impulse arrives, the vesicle
is emptied and DA is released. DA receptors on the
cell membrane can bind to the neurotransmitter, thus
transmitting the information. However, neurotransmitters
can interact among them. 5-HT antagonist can be
enhanced by amphetamine-induced locomotor activity (2)
and can inhibit dystonia and catalepsy caused by diazepam
(3).
However, to this day, little is known about the effects
of ketamine on the levels of GABA, DA, NE, 5-HT, and
* Correspondence: gaoli43450@163..com
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5-HIAA in neurocyte cell cultures from fetal rats. We
thus decided to investigate how different concentrations
of ketamine may affect these neurotransmitters at the
neurocyte level.
2. Materials and methods
2.1. Animals
Male and female Wistar rats, 3 months old and weighing
200 ± 20 g, were purchased from the Animal Experimental
Center of the Second Affiliated Hospital of Harbin Medical
University (Harbin, China). Prior to the experiment, rats
were quarantined for 2 weeks at the Northeast Agricultural
University (Harbin, China). A total of 104 rats were
randomly divided into low-dose groups (L group, n =
32, 4 subgroups), middle-dose groups (M group, n = 48,
6 subgroups), and high-dose groups (H group, n = 24, 3
subgroups), with 8 rats in each subgroup. Intraperitoneal
injections of ketamine (Shenyang Veterinary Drug Factory,
20110908) were as follows: L group with 10, 20, 30, and 40
mg/kg; M group with 50, 60, 70, 80, 90, and 100 mg/kg;
and H group with 150, 200, and 300 mg/kg. Cerebrospinal
fluid was sampled from the cisterna magna as described
previously (4). Cerebrospinal fluid was extracted from the
foramen magnum to measure the ketamine concentration
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by high-performance liquid chromatography (HPLC,
Waters 600). All experiments were performed in
accordance with the Ethical Committee for Animal
Experiments (Northeast Agricultural University, Harbin,
China).
2.2. Mating
Twelve Wistar rats were divided into 4 cages (one male
and two females per cage) with an iron mesh on the
bottom. On the next morning the vaginal suppository was
observed under the iron mesh. When sperm was observed,
the female rats were recorded as pregnant at day 0.
2.3. Determination of ketamine concentration via HPLC
2.3.1. Sample preparation
For the L group, cerebrospinal fluid was extracted from the
foramen magnum 10 min after the intraperitoneal injection
of ketamine; for the M and H groups, cerebrospinal fluid
was collected immediately upon observing the loss of
the righting reflex. First 0.5 mL of cerebrospinal fluid
was added to 50 µL of sodium hydroxide (2 mol/L)
and 5 mL of extraction solution (hexane : isopropanol :
dichloromethane = 64:3:33) and mixed by vortexing for
30 s. Samples were repeatedly shaken for 20 min and
the upper liquid part was absorbed. Samples were then
blow-dried at 60 °C by nitrogen, dissolved in 1 mL of the
mobile phase (methanol : phosphate = 13:7), vortexed for
30 s, and filtered with 0.22-µm microporous membranes
(Millipore) for use.
2.3.2. Standard ketamine solution
A concentration gradient was obtained by diluting a
standard ketamine solution (provided by the Department
of Clinical Surgery of Veterinary Medicine, Northeast
Agricultural University) to final concentrations of 10,
5, 2.5, 2, 1, and 0.5 µg/mL with ultrapure water, filtered
through 0.22-µm microporous membranes for use.
2.3.3. Sample recovery rate
To analyze the recovery rate of ketamine, cerebrospinal
fluid samples were divided into 3 parts, and equal volumes
of ketamine standard solution at 1 µg/mL, 2 µg/mL, and 5
µg/mL were added.
2.3.4. Determination of precision
In order to evaluate the precision of our measurements,
the injection of each concentration of standard solution
was repeated four times a day, thus measuring peak height
values and the coefficient of variation. The effect of different
days was evaluated by injecting each concentration of
standard solution 4 times in 4 days and measuring the
peak height and the coefficient of variation.
2.3.5. Sample measurements
The column was a symmetrical C18 (4.6 mm × 150 mm,
5 µm, US Waters Company), the flow rate of the mobile
phase (methanol : phosphate = 13:7) was 1.0 mL/min, the
detection wavelength was 220 nm, the column temperature

was 30 °C, and the injection volume was 20 µL. The utilized
external standard cerebrospinal fluid concentration of
ketamine was measured using the external standard.
2.4. Cell culture and identification of neural cells
Pregnant rats were euthanized at day 16–18 by cervical
dislocation, and embryos were recovered to collect the
hippocampus and cerebral cortex used for culturing
neural cells (5). The cells were cultured in BME (GIBCO)
supplemented with 10% (v/v) fetal bovine serum (FBS)
and penicillin/streptomycin (100 U/mL and 100 µg/mL)
at 37 °C under an atmosphere of 5% CO2 and 95% air. The
verification of cultured cells was performed as follows.
After removing the cell culture fluid, cells were fixed with
1 mL of paraformaldehyde/sugar mixture for 10 min and
then placed in 1 mL of 0.1% (v/v) Triton X-100 for 10 min
at room temperature. Cells were washed twice with PBS,
then mixed with 10% FBS (Invitrogen, Cat. No. 16140071)
for 1 h. Cells were then incubated with a mouse antiMAP2 antibody (1:200, EnoGene Biotech) overnight at
4 °C, followed by goat antimouse IgG (1:100, Santa Cruz
Biotechnology) for 1 h, and then washed three times with
PBS. Green fluorescence was observed in the cytoplasm
of cells positive for neuron-specific enolase by inverted
microscope (Nikon Eclipse Ti-S).
2.5. GABA, DA, NE, 5-HT, and 5-HIAA measurements
via LC-MS/MS
2.5.1. Solution preparation
The ratio of standard dissolving liquid was water :
acetonitrile : 0.1% formic acid = 50:25:25. The precision
weights of GABA, DA, NE, 5-HT, and 5-HIAA with
a standard of 0.0040 g were dissolved in standard
dilutions of 40 mL, targeting a concentration of 100 µg/
mL standard stock solution, stored at 4 °C. The standard
dilution preparation of cell culture medium was 10%. For
formulated 5 mmol/L ammonium formate, mobile phase
A was 5 mmol/L ammonium formate : acetonitrile = 95:5,
and mobile phase B was 5 mmol/L ammonium formate :
acetonitrile = 85:15.
2.5.2. Chromatographic conditions
The column was an XBridge BEH Amide XP Column (2.1
mm × 100 mm, 1.7 µm, US Waters Company). Column
temperature was 30 °C, flow rate was 0.25 mL/min, and
injection volume was 5 µL; an external standard was
used. Mobile phase A was 5 mmol/L ammonium formate
: acetonitrile = 95:5, and mobile phase B was 5 mmol/L
ammonium formate : acetonitrile = 85:15; the gradient
elution program is shown in Table 1.
2.5.3. MS conditions
The ion source was ESI+ and the scan mode was multiple
reaction monitoring. Capillary voltage was kept at 2.5 kV,
while the source temperature was set at 15 °C and N2 was
used as the dissolving gas with a dissolving temperature
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Table 1. Gradient table of mobile phases.
Time (min)

Flow velocity (mL/min)

%A

%B

Curve

0

0.25

100

0

6

3.50

0.25

70

30

6

3.60

0.25

100

0

6

5.00

0.25

100

0

6

of 450 °C. The dissolving gas flow rate was maintained at
650 L/h. The cone gas flow rate was kept at 50 L/h, Ar2 was
used as the collision gas, and the collision chamber working
pressure was 3.3 × 10–3 mbar. Ions and all other quantitative
and qualitative parameters are listed in Table 2.
2.5.4. Sample preparation
According to ketamine cerebrospinal fluid concentrations
detected during anesthesia in the rats, four concentrations
of ketamine for the nerve cells were determined. Ketamine
was added on day 7 to the nerve cell culture, and 40 µL
of supernatant was collected after dosing for 0, 5, 10, 15,
20, 25, 30, 45, 60, 90, and 120 min. Injection volumes of 5
µL and injection preparation vials were used and samples
were filtered through a 0.22-µm filter membrane.
2.5.5. Linearity range and correlation coefficient
The precise amount of standard stock solution with
standard dilution was diluted to concentration gradients
of 1000, 500, 200, 100, 50, 20, and 10 ng/mL. Subsequent
to filtering via 0.22-µm filter membranes, injections of 5
µL were administered.

2.5.6. Sensitivity measurement
According to the noise ratio (S/N), the values of the
minimum detection limit and lower limit of quantification
in the blank matrix were determined, five different levels
of mixed standard solution were added, and different
concentration gradients of the solution were formulated.
Signals (peak height of the ratio of the count) and noise
were measured when the lowest concentration of S/N > 3
reached the lowest concentration limit of detection at S/N
> 10, and when recovery and relative standard deviations
were in line with the requirements of the residue detection
method they reached the minimum of the limit of
quantitation.
2.5.7. Accuracy and precision
A blank sample was prepared with 100, 200, and 500
ng/mL concentrations of three quality control samples
according to earlier detection and treatment methods. Five
samples were prepared per concentration to determine the
daily coefficients of variation. The time for each sample
was checked until experimental UPLC-MS/MS methods

Table 2. Retention times and MS/MS parameters for neurotransmitter.
Elemental
composition

Parention
(m/z)

GABA

C4H9NO2

104.2

DA

C8H12NO2

154.1

NE

C8H11NO3

170.1

5-HT

C10H12N2O

177.2

5-HIAA

C10H11NO3

192.1

Neurotransmitters
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Molecular
structure

Characteristicion
(m/z)

Retention
times (s)

Cone
voltage
(V)

Collision
energy
(eV)

87.1

0.1

10

15

69.2

0.1

15

15

119

0.1

20

10

137.1

0.1

20

20

134.9

0.1

15

15

152.1

0.1

15

10

135.9

0.1

20

5

159.1

0.1

20

6

146.2

0.1

15

15
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for 5 min/day could be analyzed for all treated samples.
Therefore, coefficients of variation were not measured
that day and the methodological precision was evaluated
according to the following formula: precision standard
deviation (daily coefficients of variation) = standard
deviation / average × 100%.
Each concentration of five sample analyses used analyses
of 5-µL injections to obtain the corresponding peak areas
for each sample with the theoretical concentrations of
added standard amount ratio calculations as the method
of recovery.
2.6. Statistical analysis
All data were analyzed with GraphPad Prism 5.1
(GraphPad Software Inc., USA) by using one-way ANOVA
followed by Turkey’s post hoc test. Values were considered
to be statistically significant at P < 0.05. Data are presented
as mean ± standard deviation.
3. Results
3.1. Results of mating
Pessaries were checked under the iron mesh and smeared
sperm was removed from the vagina and examined under
a microscope. Day 0 was the day on which pregnancy was
recorded.
3.2. Determination of the administration concentration
of cells
3.2.1. Determination of ketamine in rat cerebrospinal
fluid
The retention time obtained for ketamine was 6.498 min,
showing a clear peak without interference and smearing.
Thus, endogenous substances present in the cerebrospinal
fluid did not interfere with the determination assay of
ketamine (Figure 1a).

3.2.2. Linearity range and correlation coefficient
Linear regression was performed with standard ketamine
concentration and peak area. Results showed a good linear
relationship in the range of 0.5–10 µg/mL (Figure 1b).
3.2.3. Sample recovery rate
The average recovery rate of ketamine was 96.17%, thus
indicating that the used chromatographic conditions were
reliable and the detection rate was high (Figure 1c).
3.2.4. Determination of assay precision
Daily coefficients of variation of ketamine were 2.1%,
1.4%, 0.9%, and 1.6%, while daytime coefficients of
variation were 2.1%, 2.3%, 1.2%, and 0.7%, respectively.
The coefficient of variation was below 4%, indicating that
the method was stable and reproducible.
3.2.5. Sample measurement
Rats were anesthetized using ketamine anesthesia. The
blood concentration was measured, and we found that the
concentrations of ketamine acting on nerve cells were 0.7,
1, 3, and 5 µg/mL (Table 3).
3.3. Nerve cell culture and verification
Morphological changes of nerve cells were continuously
observed under a microscope for 8 days. We observed the
shape of embryonic neuronal cells that were round, small,
bright, and scattered. Once seeded, after 3 h the cells adhered
to the dish wall. After 4 days of culturing, the cells were
significantly increased, with multiple protrusions growing
out from the cell body. In this phase neurons showed their
typical morphological characteristics, such as clear cell
body, bright and raised, with adjacent cell processes that
can form contacts (Figure 2a). After 8 days of culturing,
neuronal cell bodies increased, showing a distinct nucleus,
and cell protrusions further increased and cells appeared to
be moving closer to each other (Figure 2b).

Figure 1. a) RP-HPLC chromatogram for ketamine standards (10 µg/mL), b) data for linearity and correlation coefficients (R2), c)
recovery rate of sample.
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Table 3. Variety of cerebrospinal fluid concentrations in rats with different doses (µg/mL, n = 3).
Group

L group

M group

H group

Injection dose (mg/kg)

Cerebrospinal fluid drug concentration (µg/mL)

10

0.681 ± 0.048

20

0.784 ± 0.040

30

0.780 ± 0.081

40

0.899 ± 0.069

50

1.324 ± 0.101

60

1.251 ± 0.083

70

2.496 ± 0.215

80

2.889 ± 0.199

90

3.824 ± 0.365

100

4.925 ± 0.318

150

5.538 ± 0.294

200

6.010 ± 0.485

300

6.823 ± 0.517

Figure 2. a) Observation of fetal rat cerebral cortex nerve cells cultured in vitro for 4 days, b) observation of fetal rat cerebral cortex nerve
cells cultured in vitro for 8 days, c) comparative observation of fetal rat cerebral cortex nerve cells cultured for 7 days, d) comparative
observation of fetal rat cerebral cortex nerve cells cultured for 7 days.
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Upon observation by laser confocal microscopy,
cultured cortical neurons showed positivity for MAP2
(Figures 2c and 2d), a marker in neurons from primitive
cell cultures.
3.4. Establishment of LC-MS/MS detection method
3.4.1. Selection of MS conditions
The retention time of GABA, DA, NE, 5-HT, and 5-HIAA
chromatographic peaks were as follows: 104.2, 154.1,
170.1, 177.2, and 192.1 m/z. The separation occurred in
less than 2 min, and the peak shapes were good, as shown
in Figures 3a–3e.
3.4.2. Standard curve and linear range
The standard stock solutions were diluted to final
concentrations of 1000, 500, 200, 100, 50, 20, and 10 ng/
mL in order to perform the LC-MS/MS analysis (Table 4).
3.4.3. Determination of the detection limit and
quantification limit
To determine the detection limit and quantification limit
of neurotransmitters in the analyzed samples we measured
the lowest concentration of neurotransmitters when the
S/N ratio was ≥3, revealing that the minimum detection
limit was 6 ng/mL. On the other hand, the minimum
quantitative limit when S/N was ≥10 was 20 ng/mL.

3.4.4. Results of GABA, DA, NE, 5-HT, and 5-HIAA
recovery
Neurotransmitters at 100, 200, and 500 ng/mL were added
to samples obtaining a good precision (CV less than
12%). The average recovery rate was 89.04%–97.29%. The
accuracy and recovery rate of the tests are reported in
Table 5.
3.5. Detection of the five neurotransmitters
3.5.1. Effect of different concentrations of ketamine on
GABA
In the rat group treated with 0.7 µg/mL of ketamine, the
content of GABA had a significant increase (P < 0.01)
at 60 and 90 min, respectively, compared with 0 min. In
the rat group treated with 1 µg/mL of ketamine, GABA
content significantly decreased (P < 0.01) at 10, 15, and
20 min, respectively, thereafter increasing. The rat group
treated with 3 µg/mL of ketamine showed a decrease of
GABA at 10, 15, 20, and 25 min, respectively, followed
by an increase at 60 and 90 min (P < 0.05). Finally, when
treated with 5 µg/mL of ketamine the content of GABA
significantly (P < 0.01) decreased at 10, 15, and 20 min
and then increased at 45, 60, and 90 min, respectively
(Figures 4a and 4b).

Figure 3. a) LC-MS/MS analysis chromatogram of GABA, b) LC-MS/MS analysis chromatogram of DA, c) LC-MS/MS analysis
chromatogram of NE, d) LC-MS/MS analysis chromatogram of 5-HT, e) LC-MS/MS analysis chromatogram of HIAA.
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Table 4. Results of recovery (n = 3).

Test item

ketamine

Sample concentration

Addition amount

Measured quantity

Rate of recovery

(µg/mL)

(µg/mL)

(µg/mL)

(%)

1

7.41 ± 0.44

96.87%

2

8.41 ± 0.65

97.24%

5

10.99 ± 0.92

94.39%

6.65

Table 5. Recovery results.
Neurotransmitter

DA

NE

5-HT

5-HIAA

GABA

Added concentration
(ng/mL)

Measured concentration
(ng/mL)

Rate of recovery
(%)

Coefficient of variation
(%)

100

92.84 ± 3.99

92.84

4.30

200

189.24 ± 7.43

94.62

3.93

500

476.08 ± 12.46

95.22

2.61

100

89.04 ± 6.91

89.04

7.76

200

186.66 ± 4.899

93.33

2.62

500

472.78 ± 8.97

94.10

1.90

100

90.22 ± 2.60

90.22

2.88

200

185.18 ± 6.12

92.59

3.31

500

481.18 ± 11.79

96.24

2.45

100

90.04 ± 2.78

90.04

3.09

200

185.06 ± 6.03

92.53

3.26

500

486.46 ± 7.34

97.29

1.51

100

90.20 ± 1.35

90.20

1.49

200

187.34 ± 6.58

93.67

3.51

500

482.64 ± 4.71

96.53

0.98

3.5.2. Effect of different concentrations of ketamine on
DA
In the rat group treated with 0.7 µg/mL of ketamine, the
content of DA was significantly (P < 0.01) increased at 10,
15, and 20 min, respectively, compared with 0 min. In rats
treated with 1 µg/mL of ketamine, the DA content was
increased at 15 min but decreased at 60 min (P < 0.01).
Rats treated with 3 µg/mL of ketamine showed an increase
in DA at 10 min and 15 min, respectively. Finally, rats
treated with 5 µg/mL of ketamine showed levels of DA
significantly (P < 0.01) increased at 5 min, 10 min, 15 min,
and 20 min, respectively (Figures 4c and 4d).
3.5.3. Effect of different concentrations of ketamine on
NE
Rats treated with 0.7 and 1 µg/mL of ketamine had
significantly (P < 0.01) increased NE at 5, 10, 15, 20, and 25
min, respectively, compared with 0 min. In the rat group
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treated with 3 µg/mL of ketamine, the content of NE was
significantly (P < 0.05) increased at 5, 10, 15, 20, and 25
min, respectively, but it decreased when rats were treated
with 5 µg/mL of ketamine (P < 0.01) (Figures 4e and 4f).
3.5.4. Effect of different concentrations of ketamine on
5-HT
We observed that different concentrations of ketamine
induced 5-HT secretion by nerve cells according to
different trends. Rats treated with 0.7 µg/mL of ketamine
showed a significant (P < 0.01) decrease of 5-HT content
at 15 min. In rats treated with 1 µg/mL of ketamine, 5-HT
content was significantly (P < 0.05, P < 0.01) increased at
45 min and 60 min, respectively. Rats treated with 3 µg/
mL of ketamine had 5-HT content significantly (P < 0.01)
decreased at 10 min; at 60 and 90 min, 5-HT content was
increased (P < 0.01), respectively. Finally, in the group
treated with 5 µg/mL of ketamine, 5-HT content was first

LI et al. / Turk J Vet Anim Sci

Figure 4. a) Content changes of GABA with different concentrations of ketamine, b) content changes of GABA with different concentrations of
ketamine, c) content changes of DA with different concentrations of ketamine, d) content changes of DA with different concentrations of ketamine,
e) content changes of NE with different concentrations of ketamine, f) content changes of NE with different concentrations of ketamine, g) content
changes of 5-HT with different concentrations of ketamine, h) content changes of 5-HT with different concentrations of ketamine, i) content changes
of 5-HIAA with different concentrations of ketamine, j) content changes of 5-HIAA with different concentrations of ketamine.

421

LI et al. / Turk J Vet Anim Sci
significantly (P < 0.05, P < 0.01) decreased at 10 and 15
min, respectively, and then it significantly (P < 0.05, P <
0.01) increased at 90 and 120 min, respectively (Figures
4g and 4h).
3.5.5. Effect of different concentrations ketamine on
5-HIAA
Rats treated with 0.7 µg/mL of ketamine showed an
insignificant (P > 0.05) trend of 5-HIAA secretion by
nerve cells. In the 1 µg/mL ketamine-treated group,
5-HIAA content was significantly increased at 60 min. In
rats treated with 3 µg/mL of ketamine, 5-HIAA content
at 45 min significantly (P < 0.01) increased with respect
to the control group. Finally, in rats treated with 5 µg/mL
of ketamine, 5-HIAA content at 10 min was significantly
(P < 0.01) decreased. However, 5-HIAA content was
significantly increased (P < 0.01) at 45, 60, and 90 min
respectively (Figures 4i and 4j).
4. Discussion
In this study, we observed that GABA, 5-HT, and 5-HIAA
showed typical behaviors of neurotransmitters, with an
initial increase followed by a decrease. These molecules
reached their lowest point at 10–15 min and increased
at 45–90 min, with a final declining trend. However, the
contents of DA and NE behaved in an opposite manner.
The changes observed in neurotransmitters showed a
dose-dependent manner: with the increase of ketamine
concentration, this tendency was clearer. This is consistent
with the clinical phenomenon in vivo (6–8).
The common HPLC method classically used to measure
neurotransmitters was not sensitive enough in this case,
due to their low concentrations in the culture medium.
Therefore, monoamine neurotransmitters (DA, NE, 5-HT,
5-HIAA) and GABA were detected by high-sensitivity
liquid chromatography coupled with mass spectrometry
(LC-MS/MS). The medium composition was complex,
so we needed to dilute the analyzed samples 10-fold with
ultrapure water in order to obtain better chromatographic
results, and the retention time of each substance was less
than 2 min.
The blood–cerebrospinal fluid barrier consists of tight
junctions among epithelial cells of the choroid plexus
structure, and it is responsible for transport of substances
between the blood and cerebrospinal fluid (9). The choroid
plexus, involved in drainage back cerebrospinal fluid,
presents solute carrier (SLC) transporter protein, able
to regulate the transport of a variety of drugs available
through the blood and cerebrospinal fluid that are
essential for nerve cells to survive (10). Moreover, it can
better reflect the brain’s extracellular fluid level through
the blood–brain barrier. As a consequence, the blood
concentration of ketamine used as an anesthetic can be
detected by analyzing nerve cells. In the range of 1–5 µg/
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mL of ketamine, we chose the following concentrations: 1,
3, and 5 µg/mL, along with the low-dose group with 0.7 µg/
mL of ketamine. Cells derived from rats belonging to the
high-dose groups were rapidly broken as we observed by
microscopy. We thus chose the above four concentrations
of ketamine.
Many anesthetics have a certain effect on ion
channels, neurotransmitter receptors, and extracellular
ion concentrations. Previous experiments indicated (11)
that volatile anesthetics inhibit the central nervous system
through the inhibition of postsynaptic and presynaptic
receptors. In the nervous system, ketamine strengthens the
role of GABA (12,13), which is an important amino acid
neurotransmitter (14,15). It has the function of excitatory
and inhibitory effect on the activity and mutual relations
of neurons.
At present, the relationship between ketamine and
the GABAA receptor is still controversial. Some studies
have shown that ketamine can enhance the inhibitory
postsynaptic currents mediated by GABA at clinically
relevant concentrations. Ketamine can stimulate GABAinduced chloride currents in Xenopus oocytes, thus
suggesting that it may have a role in GABAA receptorinvolved processes (16). L-Amino acid dehydrogenase
had no effect on the generation of ketamine anesthesia,
presynaptic GABAA neurotransmission did not require
higher levels of ketamine, or it may not have an effect
by indirect efficacy in the neural network (17). The use
of ketamine in Xenopus oocytes further showed the
relationship between ketamine and GABA.
In the central nervous system, the content of DA is
mainly determined by the synthesis rate of dopaminergic
neurons. When the action potential is triggered, DA
is released into the synaptic cleft to begin the process
of transmission. In vitro experiments showed that a
subanesthetic dose of ketamine can stimulate highaffinity D2 receptors. However, under anesthesia doses,
it can block the high-affinity D2 dopamine receptors. In
addition, Kapur and Seeman (18) reported that ketamine
has a strong affinity for the dopamine D2 receptor,
which indicates that ketamine can also regulate the
dopamine system. Several studies have demonstrated
that subanesthetic doses of ketamine can allow the rapid
release of DA to the rat forebrain cortex. When the test
was repeated, higher basal levels of DA were detected, thus
indicating that repeated application of ketamine may have
more lasting impact (19). Ketamine at 2 mM (internal
embryo exposure levels equivalent to human anesthetic
plasma concentration) significantly reduced DA levels,
indicating that DA synthesis was adversely affected (20).
In long-term ketamine-treated mice, significant increases
of DA contents were found in the midbrain (21). This
experiment showed that DA increased from 45 to 120
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min, but the difference was not significant. This may be
the result of short-term effects of ketamine.
In the central nervous system, NE is has many
physiological functions, including roles in the sleep/
wake cycle, pressure perception, the cardiovascular
system cycle, perception, and learning, but it is also an
important indicator of general anesthesia. Locus coeruleus
activity can affect the MAC of the anesthetic, and locus
coeruleus neurons are stimulated during recovery from
anesthesia (22). Reports showed that the release of
NE in the hypothalamus is increased in halothane and
isoflurane anesthesia recovery processes (23). Ketamine
can partially inhibit NE reuptake so that circulating levels
of catecholamine increase, inhibiting the central nervous
system from reabsorbing it.
5-HT is also called serotonin, an indole-alkylamine
complex synthesized by the brain. It is involved in nerve
development and other processes. 5-HIAA is an important
bioactive molecule, present in body fluids such as
cerebrospinal fluid and also in platelets. Under the action
of monoamine oxidase, 5-HT is degraded into 5-HIAA, so
the content of 5-HIAA indirectly reflects the consumption
of 5-HT in the body.
As typical inhibitory neurotransmitters, the trends
observed in levels of 5-HT and 5-HIAA were in line
with the trend of GABA, but in contrast with the trends
of DA and NE. In vitro experiments have shown that
ketamine is a 5-HT receptor agonist, which may inhibit
complex G protein-coupled receptors, such as adrenaline
and muscarinic and opioid receptors (1,24). Some

studies (25,26) used ketamine to anesthetize rats and to
detect DA, NE, 5-HT, and 5-HIAA in brain, finding that
when rats were deeply anesthetized, the 5-HT content
was increased but 5-HIAA showed an opposite trend.
The contents of NE and DA were significantly increased
during ketamine anesthesia and the recovery process.
However, the decrease of 5-HIAA may be associated with
the deepening of ketamine anesthesia (10). In our work,
the content of 5-HIAA was significantly increased upon
ketamine treatment, which may be due to the exclusion
of the effects related to complex mechanisms in vitro.
Moreover, its trend is broadly in line with that of 5-HT,
maybe because 5-HT is a precursor of 5-HIAA, and it did
not significantly affect the degradation process. However,
this aspect needs to be further investigated.
In conclusion, the direct effect of ketamine anesthetic
concentration in nerve cells results in a significant impact
on monoamine neurotransmitters and GABA. Accordingly,
with clinical changes in anesthetized rats, the role of
ketamine in anesthesia may be explained by the changes
induced in these neurotransmitters. Thus, ketamine may
act by inhibiting the production and storage of excitatory
neurotransmitters, and by promoting the generation and
storage of inhibitory neurotransmitters. The anesthetic
action may be thus related to a reduction of messenger
molecules’ relative content and related enzyme activity.
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